# Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors

> **NCT03727113** · — · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 211 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplantation
- Graft Versus Host Disease

## Interventions

- **PROCEDURE:** Optimization cohort
- **PROCEDURE:** Control cohort

## Key facts

- **NCT ID:** NCT03727113
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2023-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727113, "Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03727113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*